Friday, July 31, 2009

Borrego Solar gets $30 million for solar financing

SAN FRANCISCO (Reuters) - U.S. solar power system installer Borrego Solar Systems said it has received $30 million from Taiwan's Walsin Lihwa to offer financing to solar power project customers.

The privately held El Cajon, California-based company, a solar power contractor that serves mostly the commercial sector, said the funding will help it sell services to schools, companies and government organizations interested in renewable energy.

The funding from Walsin Lihwa, a Borrego investor and manufacturer of bare copper wire and specialty steel, comes as the solar industry is grappling with a dearth of financing for solar projects.

Many potential solar customers find it difficult to afford the steep upfront installation costs, making financing an important component for expansion of solar energy.

Borrego will be offering power purchase agreements, or PPAs, which are long-term contracts to buy power, where the customer pays typically for the power used and not for the installation of the solar system, Chief Executive Mike Hall said in an interview.

Hall said he sees "tremendous growth" in 2010 for the market with financing for solar projects improving, aided by government programs.

Hall said Borrego, which had previously received $14 million in February to help expand its business into the mid-Atlantic region and develop lower cost systems, may seek another round of project funding early next year.

The funding would be similar to the most recent round, he added.

Hall said he is looking for triple-digit growth next year, both for the company and the U.S. photovoltaic market.

"This year remains challenging and I think we will be about flat," he said. "We are looking for a pretty big year" in 2010.

Borrego could also access the public markets through an initial public offering, Hall said.

"We are not married to any particular path," he said. "We definitely think about it."

Borrego ended 2008 with $58 million in revenue and more than $90 million in contracts.





We are on Twitter, FaceBook & MySpace,
please check it out...


Follow Us On TwitterMySpace - HealthPlanHelpers




Registered Representative and securities offered through ING Financial Partners Member SIPC

14726 Ramona Ave. # 410, Chino, CA 91710

Jyot Insurance & Financial Services, Inc. is not a subsidiary of nor controlled by ING Financial Partners, Inc



PLEASE NOTE: The information being provided is strictly as a courtesy. When you link to any of the web sites provided here, you are leaving this web site. We make no representation as to the completeness or accuracy of information provided at these web sites. Nor is the company liable for any direct or indirect technical or system issues or any consequences arising out of your access to or your use of third-party technologies, web sites, information and programs made available through this web site. When you access one of these web sites, you are leaving our web site and assume total responsibility and risk for your use of the web sites you are linking to

Microsoft's Bing gains another 1 percent of U.S. search

LONDON (Reuters) - Microsoft increased its share of the U.S. Internet search market by another 1 percentage point in July, taking its combined share with new search partner Yahoo to 20.36 percent, according to data released on Monday.

Internet data firm StatCounter said Microsoft's new Bing search engine had 9.41 percent of the U.S. market in July, up from 8.23 percent in June. Google's share slipped to 77.54 percent from 78.48 percent.

Microsoft and Yahoo announced a 10-year Web search deal last week to challenge Google.

They plan to use Bing to power search queries on Yahoo's sites, with Yahoo's sales force taking responsibility for selling premium search ads to big buyers for both companies.

StatCounter said on Monday: "Bing continues to make slow but steady progress but the combined Yahoo figures suggest that the deal announced last week will have to demonstrate major future synergies if it is to make any dent in Google's dominance."

StatCounter said Google's share of the global search market slipped in July to 89.23 percent from 89.80 percent in June.

Thursday, July 30, 2009

Loews posts lower-than-expected Q2 profit

NEW YORK (Reuters) - Conglomerate Loews Corp reported a lower-than-expected second-quarter profit on Monday, but higher operating income at its CNA commercial insurance business boosted its shares by 4 percent.

The New York-based company, run by the Tisch family, posted earnings from continuing operations of $341 million, or 78 cents a share, compared with a profit of $511 million, or $1.00 a share, in the same period a year ago.

Analysts were looking for a profit of 98 cents a share, excluding items, according to Reuters Estimates.

Loews shares gained, however, after its largest holding, Chicago-based CNA Financial Corp, said net operating income increased 22 percent to $305 million, compared to $250 million in the same period a year earlier.

Loews, which also has hotel and energy businesses, owns a 90 percent stake in the commercial insurer.

Shares in CNA climbed more than 9 percent although it reported investment losses hurt by the declining value of its mortgage-backed securities holdings amid falling home prices and rising unemployment.

Diamond Offshore Drilling, in which Loews has a 50.4 percent stake, is the second biggest contributor to Loews after CNA. Loews said the deepwater drilling contractor reported second quarter net income attributable to Loews of $181 million, down almost 7 percent from $194 million in the same period a year earlier.

Loews shares climbed about 4.3 percent or $1.28 cents at $31.30 and CNA shares soared just over 9 percent to $18.59 in morning trading on the New York Stock Exchange.

(Reporting by Anurag Kotoky in Bangalore and Elinor Comlay in New York; Editing by Ratul Ray Chaudhuri and Derek Caney)

Clunker trade-ins boost July U.S. auto sales

DETROIT (Reuters) - The punishing four-year decline in U.S. auto sales may have reached a turning point this week -- just as Michael Papa handed over the keys to his 1996 Ford Explorer for a government-sponsored trade-in.

Papa, a Detroit-area restaurant owner, and thousands of other Americans took advantage over the past week of the U.S. government's "Cash for Clunkers" incentive of up to $4,500 to trade in older gas-guzzlers for newer, more fuel-efficient cars.

The sudden rush of demand at car dealerships long empty of customers quickly exhausted the $1 billion allocated for the program and drove U.S. auto sales to their highest level of 2009, analysts and industry executives said.

"I wasn't really looking for a new car, but that was a big incentive. That was the driving force to finally get rid of (the old car)," said Papa.

His Explorer had 150,000 miles on it and averaged 15 miles per gallon. The Ford Escape he got in return posts average fuel economy of 24 miles per gallon.

Without the incentive, "we would have waited another year until the car finally died for good," Papa said, while waiting to pick up the Escape at the Dean Sellers Ford dealership in Troy, Michigan.

Analysts see the success of the program turbocharging July auto sales, one of the earliest snapshots of pent-up consumer demand. The House of Representatives approved on Friday a $2 billion extension of the program and the Senate is expected to act on the bill.

"July industry sales appear to have received a nice boost over the past few days from the government's scrappage incentive," Barclays Capital analyst Brian Johnson said in a research note on Friday.

A Reuters poll of 12 analysts shows that U.S. July auto sales taken before the launch of the clunkers program showed a median forecast of 10 million vehicles on an annualized basis.

That would be up from 9.7 million in June and the strongest total since December's 10.3 million annualized sales rate.

Barclays' Johnson said that, if the initial $1 billion was exhausted in the past week, July's annualized sales rate could reach the 12 to 13 million vehicle range.

AutoNation Chief Executive Mike Jackson said it was too early to quantify the impact of the government incentive, but said it was certain to drive sales above 10 million and to the highest levels of the year.

"This is the kind of buyer that comes to market once in a decade. They buy these things and keep them forever," Jackson told Reuters. "It really is incremental business and that's why it's a brilliantly conceived stimulus program.

The July results are expected to support the view the auto industry has bottomed out after a downturn that forced General Motors Co and Chrysler into bankruptcy and saddled other automakers with deep losses.

The return of new car shoppers comes at a time when dealer inventories have been driven to unsustainably low levels, opening the door to further production increases.

U.S. auto sales have dropped to their lowest since the early 1980s with about 4.8 million sales in the first half of 2009. Sales totaled 13.2 million vehicles last year.

FORD SHINES

Ford Motor Co, the only U.S. automaker operating without emergency U.S. government loans, is seen posting sales declines of 5 percent to 10 percent, according to analysts.

That would be the smallest decline of the top six U.S. automakers and could support the view U.S. consumers are reacting favorably to Ford's decision to avoid a government bailout.

"In the last week, once the (Cash-for-Clunkers) program became official, the sales pace was elevated noticeably," Ford sales analyst George Pipas told Reuters.

The average value of the vouchers has been closer to $4,500 than to $3,500, suggesting the total units involved in the program would be less than the 250,000 estimate that has been widely circulated, Pipas said.

Industry tracking firm Edmunds.com expects GM to report a 20 percent drop in July sales, with Chrysler Group sales down nearly 40 percent, Toyota Motor Corp down 15 percent and Honda Motor Co Ltd down 14 percent.

GM emerged from bankruptcy on July 10 by selling most of its assets to a new company funded by the U.S. Treasury. Chrysler exited bankruptcy in June by completing a similar sale to a group led by Italy's Fiat SpA.

Chrysler last week started offering sales incentives of up to $4,500 per vehicle, or zero-percent financing for six years, in a bid to increase demand post-bankruptcy.

"Value is the primary motivator for most sales today," said Jesse Toprak, an analyst at Edmunds.com. "Glimmers of hope about the economy and the buzz generated by the Cash-for- Clunkers program are also working in the auto industry's favor."

(Reporting by Soyoung Kim, additional reporting by Kevin Krolicki and David Bailey; editing by Gunna Dickson and Andre Grenon)







We are on Twitter, FaceBook & MySpace,
please check it out...


Follow Us On TwitterMySpace - HealthPlanHelpers




Registered Representative and securities offered through ING Financial Partners Member SIPC

14726 Ramona Ave. # 410, Chino, CA 91710

Jyot Insurance & Financial Services, Inc. is not a subsidiary of nor controlled by ING Financial Partners, Inc



PLEASE NOTE: The information being provided is strictly as a courtesy. When you link to any of the web sites provided here, you are leaving this web site. We make no representation as to the completeness or accuracy of information provided at these web sites. Nor is the company liable for any direct or indirect technical or system issues or any consequences arising out of your access to or your use of third-party technologies, web sites, information and programs made available through this web site. When you access one of these web sites, you are leaving our web site and assume total responsibility and risk for your use of the web sites you are linking to

Wednesday, July 29, 2009

FDA fast tracks Shire on Genzyme woes

Shire plc is reporting that the FDA will allow the company to distribute its treatment for Gaucher disease before FDA approval, to blunt the effect of a shortage of the only drug on the market, Genzyme’s Cerezyme.

UK based Shire, whose Human Genetic Therapies division is headquartered in Cambridge and Lexington, also released positive phase 3 data for the Gaucher drug, called velaglucerase alfa. The company also announced that it has begun filing portions of the New Drug Application for the medication, and will finish its submission by the end of this quarter.

“We are very pleased with the progress of the velaglucerase alfa program from both a clinical and regulatory perspective,” said Sylvie Gregoire, President of Shire Human Genetic Therapies. “This data are consistent with those previously reported from the Phase I/II and extension studies. We will continue to work diligently with the FDA and other regulatory agencies to make velaglucerase alfa available as soon as possible to help meet the needs of the Gaucher community.”

Shire officials say they are conducting the largest and most comprehensive set of Phase III clinical trials conducted to date for Gaucher disease. More than 100 patients at 24 sites in 10 countries around the world have participated in the clinical studies.

The first trial in the Phase III program to be completed was a multicenter, randomized, double-blind, two dose study of velaglucerase alfa in patients with Type 1 Gaucher disease. The primary goal of this study was to evaluate the safety and efficacy of velaglucerase alfa in 25 patients with Type 1 Gaucher disease.

The the first phase 3 trial, velaglucerase alfa was found to be generally well tolerated with no drug-related serious adverse events reported in the trial. No patients withdrew from the trial due to an adverse event. Most of the drug-related adverse events were reported in association with velaglucerase alfa infusions, all of which were mild and resolved without long-lasting effects.

The only Gaucher disease treatment currently on the market is Cerezyme, made by Cambridge-based Genzyme Corporation. Genzyme’s production cannot currently meet projected demand following a temporary closure at the company’s manufacturing facility in Allston, due to contamination by a virus. Genzyme has resumed production of the medicine but it takes four months to develop from start to finish.

Gaucher disease results from a specific enzyme deficiency in the body, caused by a genetic mutation received from both parents. This panethnic disease involves many organ systems, such as liver, spleen, lungs, brain, metabolism and bone marrow.

Worldwide, the diagnosed population of Gaucher Disease patients is approximately 7,000.

UPDATE 2-Savient plunges after FDA declines gout drug approval

Shares of Savient Pharmaceuticals Inc (SVNT.O: Quote, Profile, Research, Stock Buzz) fell as much as 36 percent on Monday, a day after U.S. regulators declined to approve its experimental gout drug Krystexxa.

Savient shares touched a low of $10.00, making them one of the top percentage losers on Nasdaq, before recouping some loses to trade down $3.74 at $11.85 in Monday afternoon trade.

"Our confidence in Krystexxa ultimate approval remains high as the complete response letter included draft labeling and no requirement for additional clinical trials," Cowen & Co analyst Eric Schmidt wrote in a note to clients.

Leerink & Swann analyst Joseph Schwartz said companies interested in acquiring Savient -- which is viewed by analysts as an attractive acquisition candidate -- may not wait until Krystexxa is approved as the stock is cheaper now.

Savient said on Sunday the U.S. Food and Drug Administration issued a "complete response letter", saying the agency cannot approve the drug at this time.

The FDA cited "deficiencies with the chemistry, manufacturing and controls (CMC)" section of the company's marketing application, Savient said.

"There are five areas addressed within the complete response letter: CMC, BTG-Israel facility inspection observation remediation, proposed labelling, proposed risk evaluation and mitigation strategy or REMS submission and follow-on safety update," the company said in a conference call on Monday.

Cowen's Schmidt said the FDA noted that the manufacturing process was different from the process used to generate drug for the late-stage trials and Savient will now revert to and revalidate the original manufacturing process in order to address this issue.

"In terms of the REMS program, Krystexxa will require a medication guide to ensure safe use, and a communication guide for prescribers to warn of severe infusion reactions," the analyst said.

The company said it plans to resubmit its application to the FDA by early 2010.

"We are encouraged by the benign nature of the complete response, and believe that these issues can be resolved on or potentially ahead of management's guidance for biological licence application resubmission in early 2010," Leerink's Schwartz said.

Schwartz, who has an "outperform" rating on Savient shares, expects the resubmission to receive a Class I response, which typically means the regulators would review the drug within 60 days. (Additional reporting by Toni Clarke in Boston; Editing by Maju Samuel, Anne Pallivathuckal)

Tuesday, July 28, 2009

Gym Class Injuries Up 150 Percent

MONDAY, Aug. 3 (HealthDay News) -- Just as many schools are ramping up physical education programs to battle the childhood obesity epidemic, the number of kids being injured during gym class has risen dramatically, Ohio State University researchers report.

In fact, between 1997 and 2007, the annual number of injuries related to physical education (PE) increased 150 percent -- from 24,000 in 1997 to about 62,000 in 2007, the scientists said.

"We don't have an answer as to why injuries are increasing," said lead researcher Lara McKenzie, principal investigator at the Center for Injury Research and Policy at the Research Institute at Nationwide Children's Hospital in Columbus.

"I don't think it's because more people are participating in PE," she said. "From all accounts, participation is down over the last couple of decades, and [there's been] only a slight increase in the past couple of years."

The report is published online Aug. 3 in Pediatrics.

For the study, McKenzie's team used data from the National Electronic Injury Surveillance System of the U.S. Consumer Product Safety Commission to gather information on PE-related injuries. During the 11 years of the study, 405,305 children and adolescents were treated in emergency departments for injuries stemming from their PE classes, the researchers found.

"Most of the patients, about 98 percent of the cases, were seen and released," McKenzie said. "Of those who were hospitalized, about 75 percent were boys."

Almost 70 percent of the injuries happened during running, basketball, football, volleyball, soccer or gymnastics, she said.

Injuries differed for boys and girls, she noted. Boys were more likely to be injured on the head, during collisions with other people and during group activities. Girls were more apt to suffer strains and sprains to the legs and to be injured during individual activities.

Most injuries (52 percent) occurred among kids in middle school, McKenzie said.

Given the increasing recognition of the importance of physical activity, the authors suggested that more research is needed to develop injury-prevention strategies.

And McKenzie stressed that living an active lifestyle is important, especially for children. "Parents and school administrators have to be vigilant about these types of injuries because there are so many," she said.

Pete McCall, an exercise physiologist with the American Council on Exercise, said he thinks that gym class injuries are increasing because young children are being taught how to play sports rather than being given basic training in movement and body awareness in elementary school.

Before children start playing sports, he said, they need to develop movement skills.

"If kids aren't out moving and playing before they are 9 or 10, they are not going to develop a lot of the motor skills they need when they are older," McCall explained.

He said that movement training should start early. "As a kid is 2 or 3, get him into gymnastics or martial arts or dance," McCall said. "Between 4 and 8, don't worry about sports."

"Sports should be secondary to movement," he said. "Movement skills should be first -- controlling balance, controlling center of gravity. And then, once kids understand that and have the body awareness, then they can progress into more advanced and more challenging sports."

McCall also suggests that children participate in several sports, not just one.

"Kids who grow up playing multi-sports are a lot more resistant to injury because they are used to different patterns of movement," he noted.

Vitamin D Deficiency Linked to Heart Risk Factors in Kids

MONDAY, Aug. 3 (HealthDay News) -- Most American youngsters aren't getting enough vitamin D, and that deficiency is associated with an increased incidence of risk factors for cardiovascular problems such as heart attack and stroke, two new studies find.

Simultaneous publication of both papers in the Aug. 3 online edition of Pediatrics is coincidental, the lead authors of the reports said. Both used U.S. data from the 2001-2004 National Health and Nutrition Examination Survey, and both were initiated because of a lack of information about the possible effects of low vitamin D levels on cardiovascular risk in young people.

While studies have linked vitamin D deficiency to increased risk in American adults, "few studies have looked at whether vitamin D can be associated with increased cardiovascular disease in children," said Jared P. Reis, who began his study while at Johns Hopkins University. He is now an epidemiologist in the division of cardiovascular sciences of the U.S. National Heart, Lung, and Blood Institute.

"Nobody questions that vitamin D deficiency causes rickets," said Dr. Michal L. Melamed, an assistant professor of medicine and epidemiology at Albert Einstein College of Medicine in the Bronx, who led the other study. "We wanted to explore other health outcomes and noticed that nobody had described this outcome."

The study she led looked at the overall incidence of low blood levels of vitamin D among young Americans aged 1 to 21 in the survey. There is no formal definition of vitamin D deficiency, Reis said, but many experts believe that a level of 30 nanograms per milliliter of blood is desirable.

The Melamed study found that 9 percent of young Americans -- 7.6 million -- were vitamin D-deficient, with blood levels under 15 nanograms per milliliter, and that 61 percent -- 50.8 million -- were vitamin D-insufficient, with levels between 15 nanograms and 29 nanograms per milliliter.

The high incidence of vitamin D deficiency was so surprising that "we sat on our data for six months," Melamed said. "We didn't publish until it was confirmed by other people that we had the right numbers."

Children with the lowest vitamin D levels were more likely to have higher blood pressure, high blood sugar levels and low blood levels of HDL ("good") cholesterol, the study found.

It's not entirely certain that low levels of vitamin D early in life will translate into health problems in the adult years, Melamed said. "But if you have hypertension [high blood pressure] at age 20, you have 60 more years of dealing with the consequences," she noted.

The study led by Reis was a detailed cross-sectional analysis of data on 3,577 adolescents. It found an average vitamin D blood level of 24.8 nanograms per milliliter. The average level was 15.5 nanograms per milliliter in blacks, 21.5 in Mexican Americans and 28 in whites.

There was a clear association with cardiovascular risk factors. The 25 percent of youngsters with the lowest levels of vitamin D were 2.36 times more likely to have high blood pressure, 54 percent more likely to have low HDL cholesterol levels, 2.54 times more likely to have elevated blood sugar levels and 3.88 times more likely to have metabolic syndrome, a constellation of risk factors including obesity, high blood fats and high blood pressure.

But the results should not panic parents, Reis said. "I believe we need additional research," he said. "Our study is observational, and we need additional studies to confirm it."

Specifically, parents need not turn to supplements to provide the recommended intake of vitamin D, currently set at 200 International Units a day for everyone up to age 50, Reis said. Adequate vitamin D intake can be achieved with 15 minutes a day of exposure to sunlight or consuming fortified milk, bread and other wheat products, among other foods, he said.

"Parents should focus on modifiable risk factors," Melamed said. "Children should not always be on the computer or watching television. They can drink more milk, rather than using supplements."

Monday, July 27, 2009

South Africa reports first swine flu death

JOHANNESBURG — Health officials say that a college student has become the first South African to die from swine flu.

The 22-year-old male student from the University of Stellenbosch, near Cape Town, died July 28 after being sick for a week.

Health Minister Aaron Motsoaledi said that the H1N1 virus was confirmed as the cause of death Monday.

The student went to the campus clinic with flu symptoms but was later admitted to a private hospital. He was treated for pneumonia but did not recover.
There have been more than 500 swine flu cases reported in South Africa since mid-June. Some schools in Johannesburg have temporarily closed after pupils tested positive for swine flu.






We are on Twitter, FaceBook & MySpace,
please check it out...


Follow Us On TwitterMySpace - HealthPlanHelpers




Registered Representative and securities offered through ING Financial Partners Member SIPC

14726 Ramona Ave. # 410, Chino, CA 91710

Jyot Insurance & Financial Services, Inc. is not a subsidiary of nor controlled by ING Financial Partners, Inc



PLEASE NOTE: The information being provided is strictly as a courtesy. When you link to any of the web sites provided here, you are leaving this web site. We make no representation as to the completeness or accuracy of information provided at these web sites. Nor is the company liable for any direct or indirect technical or system issues or any consequences arising out of your access to or your use of third-party technologies, web sites, information and programs made available through this web site. When you access one of these web sites, you are leaving our web site and assume total responsibility and risk for your use of the web sites you are linking to

Health insurers fighting overhaul plan with cash

As the nation faces a political showdown over health insurance reform, insurers worried that an overhaul could hurt their bottom line are funneling a wave of cash to members of Congress.

That includes Minnesota, where Republicans are the biggest beneficiaries of the industry's largesse. Sixth District Rep. Michele Bachmann, an outspoken foe of a government insurance option, is among the top recipients this year in the entire U.S. House. Third District Rep. Erik Paulsen and Second District Rep. John Kline also ranked high in contributions received.

Health and accident insurers and HMOs have spent more than $40 million on current members of Congress over the past 10 years, according to the Center for Responsive Politics, which analyzed Federal Election Commission data.

They've also spent an additional half-billion dollars lobbying during the decade.

Health insurers worry that a "public option" favored by President Obama and House Democrats could hurt private competitors and even drive some out of business.

Obama appeared to take direct aim at insurers in a town hall meeting earlier this week, when he said that the $177 billion the government spends on Medicare Advantage, a private-sector version of Medicare, offered no real advantage and could be redirected to health care reform.

Insurers find themselves ever more isolated in the national health care debate since their former allies -- the pharmaceutical and hospital industries -- have struck their own partial and tentative agreements with the White House and some Democratic members of Congress.

U.S. House Speaker Nancy Pelosi on Thursday labeled health insurers "villains," saying that "they have been a part of the problem in a major way. They are doing everything in their power to stop a public option from happening."

Friday, July 24, 2009

Germany Orders 50 Mln Doses Of Swine Flu Vaccine

FRANKFURT (Dow Jones)--Germany is ordering 50 million doses of vaccine for the A/H1N1 influenza strain, known as swine flu, the Thuringia State Health Ministry said.

The order is sufficient to vaccinate around one third of the population to follow World Health Organization recommendations to vaccinate particular groups, such as people with asthma or chronic health conditions as well as healthcare professionals, said the ministry, which is currently chairs the conference of federal and state health ministers.

The doses will cost around EUR700 million, or around one third of the roughly EUR2 billion it would cost to vaccinate the entire population, a ministry spokesman told Dow Jones Newswires.

The ministry has placed orders with two global vaccine producers, the spokesman said, but declined to name the companies. The contracts include an option to order more doses to vaccinate the entire population if necessary, he added.

Voluntary vaccinations will begin after an 8-10 week delivery period, likely in October, the ministry said.

Companies taking orders for swine flu vaccines include GlaxoSmithKline PLC (GSK.LN), Sanofi-Aventis SA (SAN.FR), Novartis AG (NOVN.VX) and Baxter International Inc. (BAX).

Governments at the federal and state level are currently ironing out details of the regulation, including to what extent health insurers will pay for the vaccine, the ministry said.





We are on Twitter, FaceBook & MySpace,
please check it out...


Follow Us On TwitterMySpace - HealthPlanHelpers




Registered Representative and securities offered through ING Financial Partners Member SIPC

14726 Ramona Ave. # 410, Chino, CA 91710

Jyot Insurance & Financial Services, Inc. is not a subsidiary of nor controlled by ING Financial Partners, Inc



PLEASE NOTE: The information being provided is strictly as a courtesy. When you link to any of the web sites provided here, you are leaving this web site. We make no representation as to the completeness or accuracy of information provided at these web sites. Nor is the company liable for any direct or indirect technical or system issues or any consequences arising out of your access to or your use of third-party technologies, web sites, information and programs made available through this web site. When you access one of these web sites, you are leaving our web site and assume total responsibility and risk for your use of the web sites you are linking to

Robert Reich says Obama ready to "knock heads" on health care reform

Robert Reich, the U.S. secretary of labor in the Clinton administration, told a conclave of healthcare executives in San Francisco Thursday afternoon that President Barack Obama needs to “start knocking heads” on health reform if he intends to get a major bill through Congress this fall.

Reich said Obama learned from some of Bill Clinton’s errors, which is why he didn’t send a detailed bill to Congress that would have been dead on arrival, like the Clinton reform proposals of the early 1990s.

But Reich, the keynote speaker at a Leadership Summit conference sponsored by Health Forum and the American Hospital Association, added that Obama probably should have started knocking heads two weeks earlier, and now risks having Congress adjourn without having settled on a bill, which could give the proposed package’s opponents more time to come up with attack plans.

Nonetheless, Reich, predicted that “you will see an Obama bill” when a joint House and Senate conference committee takes up the legislation. “That’s when Obama will play his cards,” said Reich, now a professor at the University of California at Berkeley, and a frequent commentator on economic, policy and political issues.

Reich also predicted that Obama would insist on adding some controls on medical malpractice insurance, if that’s not part of the legislation when he steps into the picture more directly, and that the president and his allies are becoming more interested in “capitation” (HMO-style pre-paid health-care) and accountable care by integrated systems like the Mayo Clinic or Cleveland Clinic, as they become aware that providing coverage to the uninsured is just one key piece of the puzzle facing would-be reformers.

“The pressure, the momentum is building” to add such features to an overall reform package, Reich said, even though the American public doesn’t like HMOs, and hasn’t shown an interest in these issues.


Chris Rauber of the San Francisco Business Times, an affiliated publication, compiled this report.

Thursday, July 23, 2009

Mass. has lessons for health care debate

BOSTON — The state that pioneered health care for all is about to take another leap into the unknown: paying for it.

Three years after mandating that residents get health insurance and requiring employers, insurers and taxpayers to chip in, Massachusetts has yet to control soaring costs that are eating up half its budget. So it's considering an equally radical idea: changing the way doctors and hospitals are paid to reward results.

As Washington wrestles with the idea of overhauling the nation's health care system, the Bay State offers an object lesson in how to do it in stages. It's an approach favored by state officials but rejected by the Obama administration, which is intent on addressing coverage, cost and quality all at once.

Massachusetts dealt with coverage first: just 2.6% of state residents remain uninsured, compared with more than 15% nationally. That's due in part to the 2006 law, which said most residents must get insurance, most employers must help provide it, and most taxpayers must help pay for it.

Dealing with cost and quality has proved trickier. Higher health care costsfueled a combined $9 billion gap in the state's 2009 and 2010 budgets that had to be closed last month, leaving less for education, public safety, the environment and other services.

"There are a few other things people want us to pay for," quips Leslie Kirwan, state secretary of administration and finance.

Quality has been an issue, too. Because more people have insurance, some doctors and safety-net hospitals are overwhelmed. A study by the non-partisan Urban Institute found one in five adults in the state have been turned away by a doctor's office or clinic.

Using Massachusetts as a partial model, President Obama is trying to tackle even more difficult coverage, cost and quality problems all at once. The president seeks to extend insurance to up to 46 million people without it. At the same time, he wants to slow the growth of Medicare and Medicaid, now projected to rise from 5% of the nation's economy to more than 17% by 2080.

Still, Massachusetts offers lessons for national policymakers as they debate the biggest change in health care delivery since Medicare and Medicaid were created nearly a half century ago:

• Peddle the plan to the public. A Republican governor at the time, Mitt Romney, and a Democratic Legislature sold it to state residents as both a moral imperative and a common-sense addition to the requirement that residents have automobile insurance.

• Don't alienate powerful interest groups. Insurers and businesses, rebelling in Washington, signed on here. The state did not create a public plan to compete with private companies; it has only a state-subsidized plan for low-income earners who don't get Medicaid or employer insurance. It required only a $295-per-worker annual fee from companies with 11 or more employees that do not offer health insurance. Plans percolating in Congress include much bigger fees.

• Prepare for years of trial and error. Government officials, providers and consumers here say they expected a lengthy, often troublesome implementation.

"This is never over," says John McDonough, who ran the statewide advocacy group Health Care for All when the law passed and is now a senior adviser to Sen. Edward Kennedy, D-Mass. "It is always messy."

The demand for insurance didn't take long to materialize.

No sooner did Massachusetts require health insurance in 2006 than hundreds of thousands of residents signed up. The number of insured soared by more than 200,000 in the first two years, at least 40,000 more than forecast, according to Commonwealth Connector, the state agency created to oversee the health plan.

The state plan is set up so that those who receive government subsidies pay no premium if their income is below 150% of the federal poverty level — $16,620 for individuals and $33,084 for a family of four. Others pay premiums based on a sliding scale and choose from an array of plans chosen by the state.

Nearly everyone is required to get insurance, unless the state deems all the available premiums too expensive. Those who don't comply face penalties up to $1,068 per year if they are at least 27 years old and earn three times the poverty level.

Exemptions can be sought by individuals earning up to $54,600 if they can't find monthly premiums below $342, and by families earning up to $114,400 if they can't find premiums below $820.

Overall, nearly 430,000 residents out of about 600,000 who were uninsured now have coverage. Virtually every type of insurance has increased: Medicaid, the new Commonwealth Care subsidy program, unsubsidized plans and those provided by employers, state data show. About 163,000 residents have taken advantage of government subsidies. Another 150,000 have chosen employer plans.

Most of those who got insurance under the Massachusetts program are grateful. Francisco Diaz of South Boston, 54 and unemployed, pays nothing for his care at the South Boston Community Health Center and is scheduled for a hip replacement next month. Lizete Rosa of Fall River, 56, laid off from her factory job in September, pays no premium and a low $10 copayment. Sandra McInerney of Chicopee, 50, a private school teacher who was unemployed for a year, pays $194 a month and $15 a visit. "I guess it's fair," she says.

Cost is 'somebody's income'

The major task facing Massachusetts now is the same one confronting the nation: controlling costs that were spiraling long before the 2006 law.

Expanding access to insurance has made that problem tougher by adding more than $700 million in annual costs, split evenly with the federal government, according to the Massachusetts Taxpayers Foundation. The annual cost to care for those who were uninsured in 2006 has risen from $1 billion to $1.7 billion.

The state saved money by reducing payments to hospitals for uncompensated care and increasing the cigarette tax by $1 per pack to help pay for the expansion. Then came the recession, forcing thousands of laid-off residents to sign up for subsidies.

Phone counselors at Health Care for All are fielding 1,100 calls a week — a demand not seen since the program's inception.

"The only thing that went wrong is we ramped up faster than we anticipated," says Jonathan Gruber, a health economist at the Massachusetts Institute of Technology and a board member of the agency that runs the state's new health insurance program.

Jon Kingsdale, that agency's executive director, says putting access before cost was intentional. It made covering the uninsured a moral imperative without forfeiting the support of providers, insurers and employers — many of whom could lose money when costs are cut. "It's a lot harder to do cost and access together," he says. "Everybody's cost is somebody's income."

The problem was punted to the payment commission, which last week recommended a system in which health care providers would be paid a set amount for each patient, with adjustments for health status and other factors. Doctors, nurses and hospitals would work as a team to manage the patient's care.

If you offer it, they will come

Once people had insurance, the state reasoned, they would flee emergency rooms for neighborhood doctors and drug stores. As a result, state funds intended to pay safety-net hospitals and community health centers for serving the uninsured have been reduced by $660 million.

But if anything, demand has increased as the newly insured seek more medical attention. "The funding levels are not keeping pace with the volume that we're seeing," says William Halpin, CEO of South Boston Community Health Center. "There's been a little bit of robbing Peter to pay Paul."

Boston Medical Center, the state's largest provider to the poor, filed a lawsuit against the state last week charging that it's getting only 64 cents on the dollar to care for low-income patients.

"We kept the patients, but we didn't keep the money," says Thomas Traylor, vice president for federal, state and local programs.

The situation is even worse at Cambridge Health Alliance, the second largest such provider. Six health centers have closed, mental health and substance abuse services cut, and Somerville Hospital no longer admits inpatients.

As the state faced a budget crisis this spring, other health care services were threatened, including dental care for 92,000 residents and all care for 28,000 legal immigrants with fewer than five years in the country. The cuts were put on hold last month, but funding still must be found.

"The message is wrong," says Eva Millona, executive director of the Massachusetts Immigrant & Refugee Advocacy Coalition. "We have been a model in the country. We should sustain that."

U.S. has bought 195 million doses of H1N1 vaccine

GAITHERSBURG, Maryland (Reuters) - The U.S. government has bought 195 million doses of H1N1 swine flu vaccine for a possible autumn vaccination campaign, a U.S. federal official said Thursday.

The U.S. Health and Human Services Department has also contracted for 120 million doses of adjuvant, a compound to stretch the number of doses of vaccine needed, the department's Dr. Robin Robinson told a meeting of Food and Drug Administration advisers.

Five companies are making H1N1 vaccine for the U.S. market -- AstraZeneca's MedImmune unit, Australia's CSL Ltd, GlaxoSmithKline Plc, Novartis AG and Sanofi-Aventis SA.

Earlier, an FDA official said vaccine makers were only getting about 30 percent as much vaccine from eggs as they usually get with seasonal influenza vaccine.

Robinson said HHS had accounted for this in planning for a possible influenza pandemic.

"We thought manufacturers would probably get a low or poor yield. That has been borne out," Robinson told the meeting.

He said HHS had planned to have 160 million doses available right away, and then 80 million a month afterward. It would take until March at this rate to vaccinate the full U.S. population of 300 million people with two doses each, Robinson said.

The five vaccine-making companies will tell the FDA committee later Thursday about what they have learned as they work with the virus, which spread globally in less than two months.

World Health Organization and U.S. health officials have said they want to start vaccinating people against H1N1, alongside regular seasonal flu, in October. The FDA has to approve this vaccine before it can be used but FDA officials indicated earlier Thursday they would like to speed this process.

Tuesday, July 21, 2009

NHS 'facing huge flu challenge'

The swine flu pandemic is presenting the NHS with its "biggest challenge in a generation", the chief medical officer believes.

Sir Liam Donaldson told the BBC the coming months would be a real test for everyone working in the health service.

Under contingency plans, non-emergency operations can be cancelled and GPs moved around the country to help cope with flu hot-spots.

His comments came as another UK swine flu death was announced, in Glasgow.

The government has already announced the National Flu Service will go live this week to relieve some of the pressure on the health service.

Dealing with this is a marathon not a sprint
Sir Liam Donaldson, Chief Medical Officer

The phone and internet service will enable people in England to get anti-flu drugs without going to their GPs.

It comes after 55,000 new cases have emerged in the past week alone, with every region but Yorkshire and the Humber starting to report "exceptional" demands on services.

But Sir Liam said it was only going to get worse.

"Dealing with this is a marathon not a sprint.

"That might involve cancelling some routine procedures but if that is necessary to treat people who are seriously ill with flu that is what will have to be done."

Deaths

It comes as more details of deaths have emerged. The UK death toll had reached 29 last week, but the Scottish government has already announced one more death this week.

The 15-year-old girl died in Glasgow a week after she was admitted to hospital.

The teenager, who had underlying health problems, is the fourth person in Scotland to die with the virus.

SWINE FLU SYMPTOMS
  • 1. High temperature, tiredness and lowered immunity
  • 2. Headache, runny nose and sneezing
  • 3. Sore throat
  • 4. Shortness of breath
  • 5. Loss of appetite, vomiting and diarrhoea
  • 6. Aching muscles, limb and joint pain Source: NHS
  • Scotland's Health Secretary Nicola Sturgeon said the death was "devastating" for her family.

    But the actual number of deaths is likely to be higher as England will not be updating its figures until later in the week.

    Elsewhere, a post-mortem examination showed a six-year-old girl from west London who had swine flu died of septic shock after suffering tonsillitis.

    Chloe Buckley from West Drayton died in St Mary's Hospital, at Paddington in west London on 9 July.

    Results from a post-mortem examination revealed she had tonsillitis caused by streptococcus A bacterium.

    But London health officials have not ruled out the possibility that swine flu contributed to her death.

    Announcing the results of the post-mortem examination, Dr Simon Tanner, regional director of public health for London, said: "We would once again like to extend our deepest condolences to Chloe's family at this difficult time and ask that the media respect their wishes to be allowed to come to terms with their loss in private."

    Chloe, who contracted the virus in the UK, attended St Catherine's School in West Drayton.

    Her parents, Michael and Jacinta, released a statement following her death on 9 July saying they were satisfied with the medical care Chloe had received and asked to be left alone to grieve.

    Worst-case scenarios

    Meanwhile in China, the first of more than 100 British school pupils quarantined at a Beijing hotel after coming into contact with students diagnosed with swine flu have been released.

    A total of 21 students and two teachers were allowed to leave the Yanxiang Hotel early on Tuesday after spending seven days in quarantine.

    The government has warned that the number of deaths from the virus this winter in the UK could reach between 19,000 and 65,000.

    But it has stressed these are worst-case scenarios and compare to the 12,000 seasonal flu deaths seen each year on average.

    Ministers have said they are not not convinced of the benefits of closing schools this autumn despite Imperial College London scientists saying such a move could help slow the spread of cases and buy more time for a vaccine.

    Friday, July 17, 2009

    House Democratic leaders pledge healthcare progress

    WASHINGTON (Reuters) - Democratic leaders in the U.S. House of Representatives on Friday hailed "historic" progress on healthcare legislation and pledged to continue momentum to deliver on President Barack Obama's vow of reform.

    "Congress has made historic progress on health insurance reform that will put patients and doctors back in charge," House Speaker Nancy Pelosi told a news conference after two House committees passed legislation aimed at overhauling the country's healthcare system.

    Other Democratic leaders said the House legislation, along with another version being developed in the Senate, would likely undergo changes before anything is sent to Obama for his signature but added that "failure is not an option."

    "These pivotal months will finally be our chance to deliver, and we will," House Majority Leader Steny Hoyer said.

    Thursday, July 16, 2009

    H1N1 pandemic spreading too fast to count: WHO

    The World Health Organization (WHO) said on Thursday that the H1N1 flu pandemic was the fastest-moving pandemic ever and that it was now pointless to count every case.

    The United Nations agency, which declared an influenza pandemic on June 11, revised its requirements so that national health authorities need only report clusters of severe cases or deaths caused by the new virus or unusual clinical patterns.

    "The 2009 influenza pandemic has spread internationally with unprecedented speed. In past pandemics, influenza viruses have needed more than six months to spread as widely as the new H1N1 virus has spread in less than six weeks," it said in a statement on the new strain, commonly known as swine flu.

    It has become nearly impossible for health authorities and laboratories to keep count of individual cases -- which have mostly been mild -- as the virus spreads, according to the 193 member-state agency.

    The new flu strain can be treated by antivirals such as Roche Holding's Tamiflu or GlaxoSmithKline's Relenza, but many patients recover without medical treatment.

    Flu experts say at least a million people are infected in the United States alone, and the WHO says the pandemic is unstoppable.

    "It is very much agreed that trying to register and report every single case is a huge waste of resources," WHO spokesman Gregory Hartl said.

    Such tracking has limited authorities' capacity to investigate serious cases and is no longer essential to monitor the level or nature of the risk posed by the virus, WHO said.

    However, all countries should still closely monitor unusual clusters of severe or fatal infections from the pandemic virus, clusters of respiratory illness requiring hospitalization or unexplained or unusual clinical patterns.

    "Signals to be vigilant for include spikes in rates of absenteeism from schools or workplaces, or a more severe disease pattern, as suggested by, for example, a surge in emergency department visits," it said.

    Britain reported on Thursday that 29 people had died to date after contracting the virus. Health Minister Andy Burnham said this month the government was projecting more than 100,000 new cases a day of the flu in the country by the end of August.

    The WHO will no longer issue global tables showing the numbers of confirmed cases for all countries -- which stood at 94,512 cases with 429 deaths as of its last update on July 6.

    Instead, it will issue regular updates on the situation in newly affected countries, which should report the first confirmed cases, weekly figures and epidemiological details.

    Countries should still test a limited number of virus samples weekly to confirm that disease is actually due to the pandemic virus and to monitor any virological changes that may be important for the development of vaccines, it said.

    At least 50 governments have placed orders for vaccines against the new H1N1 strain or negotiating with drug makers, WHO vaccine chief Marie-Paule Kieny told Reuters.

    The WHO does not report figures for cases of seasonal influenza, which it says is linked to 250,000 to 500,000 deaths a year globally.




    We are on Twitter, FaceBook & MySpace,
    please check it out...


    Follow Us On TwitterMySpace - HealthPlanHelpers




    Registered Representative and securities offered through ING Financial Partners Member SIPC

    14726 Ramona Ave. # 410, Chino, CA 91710

    Jyot Insurance & Financial Services, Inc. is not a subsidiary of nor controlled by ING Financial Partners, Inc



    PLEASE NOTE: The information being provided is strictly as a courtesy. When you link to any of the web sites provided here, you are leaving this web site. We make no representation as to the completeness or accuracy of information provided at these web sites. Nor is the company liable for any direct or indirect technical or system issues or any consequences arising out of your access to or your use of third-party technologies, web sites, information and programs made available through this web site. When you access one of these web sites, you are leaving our web site and assume total responsibility and risk for your use of the web sites you are linking to